Inflammation‐induced cholestasis

Inflammatory cytokines produced in response to various infectious and non‐infectious stimuli are potent inducers of intrahepatic cholestasis (inflammation‐induced cholestasis). The cholestatic effect of cytokines results mainly from inhibition of expression and function of hepatocellular transport systems which normally mediate hepatic uptake and biliary excretion of bile salts and various non‐bile salt organic anions (e.g. bilirubin). These cytokine effects are reversible and bile secretory function is restored upon disappearance of the inflammatory injury. This review summarizes the clinical, pathophysiological and molecular aspects of inflammation‐induced cholestasis.

[1]  J. Boyer,et al.  Molecular pathogenesis of cholestasis. , 2012, The New England journal of medicine.

[2]  J. Hoofnagle,et al.  Lymphokines and bile secretion in the rat. , 2008, Liver.

[3]  G. Farrell,et al.  Drug induced liver disease , 2000 .

[4]  A. Meshikhes,et al.  Duodenal and ampullary obstruction by a Peutz-Jeghers polyp. , 2000, European Journal of Gastroenterology and Hepathology.

[5]  G. Hegedűs.  [Pathology of alcoholic liver disease]. , 2000, Orvosi hetilap.

[6]  Pauline R. Martin,et al.  The oxford textbook of clinical hepatology , 2000, Gastroenterology.

[7]  J. Boyer,et al.  Molecular regulation of hepatocellular transport systems in cholestasis. , 1999, Journal of hepatology.

[8]  S. Glaser,et al.  Regulation of cholangiocyte bile secretion. , 1999, Journal of hepatology.

[9]  R. Evers,et al.  Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. , 1999, The Biochemical journal.

[10]  D. Häussinger,et al.  Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. , 1999, Gastroenterology.

[11]  P. Jansen,et al.  Early events in sepsis-associated cholestasis. , 1999, Gastroenterology.

[12]  R. Béliveau,et al.  Dexamethasone modulation of multidrug transporters in normal tissues , 1999, FEBS letters.

[13]  G. Hooiveld,et al.  Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .

[14]  T. Ishikawa,et al.  Expression of Multidrug Resistance Protein/GS-X Pump and γ-Glutamylcysteine Synthetase Genes Is Regulated by Oxidative Stress* , 1998, The Journal of Biological Chemistry.

[15]  K. Hirsch‐Ernst,et al.  Induction of mdr1b mRNA and P‐glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures , 1998, Journal of cellular physiology.

[16]  T. Chan,et al.  Treatment of fibrosing cholestatic hepatitis with lamivudine. , 1998, Gastroenterology.

[17]  J. Boyer,et al.  Clinicopathology conferences: Inflammation‐induced cholestasis , 1998, Hepatology.

[18]  J. Boyer,et al.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. , 1998, The Journal of clinical investigation.

[19]  L. Burgart.  Cholangitis in viral disease. , 1998, Mayo Clinic proceedings.

[20]  J. McGill,et al.  Cholestatic liver diseases in adults , 1998, American Journal of Gastroenterology.

[21]  P. Meier,et al.  The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.

[22]  D. Schrenk,et al.  Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. , 1998, Biochemical and biophysical research communications.

[23]  L. Denson,et al.  Identification of a novel negative-acting cytokine response element in the rat liver sodium-dependent bile acid cotransporter gene promoter , 1998 .

[24]  B. Rowlands,et al.  Conclusive evidence of endotoxaemia in biliary obstruction , 1998, Gut.

[25]  P. Meier,et al.  Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver , 1997, Hepatology.

[26]  K. Lindsay.  Therapy of hepatitis C: Overview , 1997, Hepatology.

[27]  H. Bonkovsky.  Therapy of hepatitis C: Other options , 1997, Hepatology.

[28]  M. Strazzabosco.  New insights into cholangiocyte physiology. , 1997, Journal of hepatology.

[29]  E. Mazzon,et al.  Hepatocyte tight-junctional permeability is increased in rat experimental colitis. , 1997, Gastroenterology.

[30]  P. Meier,et al.  Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Kagnoff,et al.  Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. , 1997, The American journal of physiology.

[32]  C. Gartung,et al.  Molecular regulation of sinusoidal liver bile acid transporters during cholestasis. , 1997, The Yale journal of biology and medicine.

[33]  D. Keppler,et al.  The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.

[34]  M. Trauner,et al.  Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations. , 1997, The Yale journal of biology and medicine.

[35]  Ge Zhou,et al.  NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.

[36]  R. Shoemaker,et al.  Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. , 1997, Journal of the National Cancer Institute.

[37]  M. Letizia,et al.  Drug-induced hepatic injury. , 1997, Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses.

[38]  J. Boyer,et al.  Endotoxin impairs biliary glutathione and HCO3− excretion and blocks the choleretic effect of nitric oxide in rat liver , 1997, Hepatology.

[39]  J. Crawford.  CELLULAR AND MOLECULAR BIOLOGY OF THE INFLAMED LIVER , 1997 .

[40]  F. Carnot,et al.  Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. , 1997, Transplantation.

[41]  A. Guarino,et al.  Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. , 1996, Gastroenterology.

[42]  F. Suchy,et al.  Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis. , 1996, The American journal of physiology.

[43]  D. Beier,et al.  Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. , 1996, Gastroenterology.

[44]  D. Keppler,et al.  cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.

[45]  J. Lau,et al.  Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation , 1996, Hepatology.

[46]  T. Pruett,et al.  Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation , 1996 .

[47]  P. Bosma,et al.  Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.

[48]  P. Meier.  Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile. , 1995, The American journal of physiology.

[49]  R. Green,et al.  Tumor necrosis factor–alpha decreases hepatocyte bile salt uptake and mediates endotoxin‐induced cholestasis , 1995, Hepatology.

[50]  M. Trauner,et al.  Nitric oxide and liver disease. , 1995, Der Gastroenterologe.

[51]  P. Jansen,et al.  Impaired hepatocanalicular organic anion transport in endotoxemic rats. , 1995, The American journal of physiology.

[52]  D. Häussinger,et al.  Metabolism of cysteinyl leukotrienes in the perfused rat liver: The influence of endotoxin pretreatment and the cellular hydration state , 1995, Hepatology.

[53]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[54]  M H Nathanson,et al.  Altered expression and function of hepatocyte gap junctions after common bile duct ligation in the rat. , 1995, The American journal of physiology.

[55]  J. Dufour,et al.  Nitric oxide blocks bile canalicular contraction by inhibiting inositol trisphosphate-dependent calcium mobilization. , 1995, Gastroenterology.

[56]  N. Hayashi,et al.  Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. , 1995, Journal of hepatology.

[57]  D. Beier,et al.  Interleukin-6 inhibits hepatocyte taurocholate uptake and sodium-potassium-adenosinetriphosphatase activity. , 1994, The American journal of physiology.

[58]  C. Kleeman,et al.  Endothelin receptor in osteoblastic cells is coupled to multiple messenger signals. , 1994, The American journal of physiology.

[59]  R. O. Oude Elferink,et al.  Decreased bilirubin transport in the perfused liver of endotoxemic rats. , 1994, Gastroenterology.

[60]  S. Durrant,et al.  Fatal Reactivation of Precore Mutant Hepatitis B Virus Associated with Fibrosing Cholestatic Hepatitis after Bone Marrow Transplantation , 1994, Annals of Internal Medicine.

[61]  P. Gros,et al.  Phosphatidylcholine translocase: A physiological role for the mdr2 gene , 1994, Cell.

[62]  Warner As,et al.  Extrahepatic Hodgkin's disease and cholestasis. , 1994 .

[63]  C. Lieber.  Alcohol and the liver: 1994 update. , 1994, Gastroenterology.

[64]  P. Meier,et al.  Expression cloning of a rat liver Na(+)-independent organic anion transporter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Jane W. S. Fang,et al.  Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B , 1993, The Lancet.

[66]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[67]  O. Bulbena,et al.  Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia , 1993, Hepatology.

[68]  A. Hori,et al.  Cytomegalic inclusion disease presenting acute intrahepatic cholestasis. , 1992, Internal medicine.

[69]  Randall G. Lee,et al.  Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. , 1992, Gastroenterology.

[70]  J. Fitz,et al.  Paraneoplastic hepatopathy associated with soft tissue sarcoma. , 1992, Gastroenterology.

[71]  S. Davies,et al.  High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. , 1992, Gastroenterology.

[72]  A. Huggett,et al.  Dexamethasone prevents the growth inhibitory effects of recombinant tumor necrosis factor in a rat hepatoma cell line Reuber-RC-3: an association with the changes in the messenger RNA levels for multidrug resistance gene. , 1991, Biochemical and biophysical research communications.

[73]  P. Meier,et al.  Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[74]  C. Bode,et al.  Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. , 1991, Journal of hepatology.

[75]  A. Khoruts,et al.  Circulating tumor necrosis factor, interleukin‐1 and interleukin‐6 concentrations in chronic alcoholic patients , 1991, Hepatology.

[76]  S. Davies,et al.  Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis , 1991, Hepatology.

[77]  M. Gore,et al.  Tumour necrosis factor, cholestatic jaundice, and chronic liver disease. , 1990, Gut.

[78]  S. Sherlock.  Diseases of the Liver and Biliary System. 8th ed , 1990 .

[79]  D. Kershenobich,et al.  [Cytokines and the liver]. , 1990, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[80]  G. Alexander,et al.  Increased plasma tumor necrosis factor in severe alcoholic hepatitis. , 1990, Annals of internal medicine.

[81]  B. Garra,et al.  Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  J. Nolan.  Intestinal endotoxins as mediators of hepatic injury—An idea whose time has come again , 1989, Hepatology.

[83]  J. Priest,et al.  Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma. , 1989, Gastroenterology.

[84]  V. Guetta,et al.  Abnormalities in bilirubin and liver enzyme levels in adult patients with bacteremia. A prospective study. , 1989, Archives of internal medicine.

[85]  M. Pirovino,et al.  Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection. , 1989, Gastroenterology.

[86]  R. Hoffmann,et al.  Serial bilirubin determinations as a prognostic marker in clinical infections. , 1989, The American journal of the medical sciences.

[87]  W. Gerok,et al.  The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes. , 1989, Journal of hepatology.

[88]  N. Bergasa,et al.  Clinical significance and pathogenesis of hyperbilirubinemia associated with Staphylococcus aureus septicemia. , 1988, The American journal of medicine.

[89]  M MurieCarrillodeAlbornoz,et al.  [Toxic and drug-induced hepatitis]. , 1988 .

[90]  J. Lamont,et al.  Postoperative Jaundice , 1988, Seminars in liver disease.

[91]  J. Hoek,et al.  Functional Implications of the Interaction of Ethanol with Biologic Membranes: Actions of Ethanol on Hormonal Signal Transduction Systems , 1988, Seminars in liver disease.

[92]  D. Tuma,et al.  Effects of Ethanol on Protein Trafficking in the Liver , 1988, Seminars in liver disease.

[93]  M. Birrer,et al.  Differential Diagnosis of Jaundice in Lymphoma Patients , 1987, Seminars in liver disease.

[94]  C. Crespi,et al.  Different course of acute hepatitis B in elderly adults. , 1985, Journal of Gerontology.

[95]  E. Schiff,et al.  Prolonged intrahepatic cholestasis secondary to acute hepatitis A. , 1984, Annals of internal medicine.

[96]  A. Braillon,et al.  METRONIDAZOLE IN PREVENTION OF CHOLESTASIS ASSOCIATED WITH TOTAL PARENTERAL NUTRITION , 1983, The Lancet.

[97]  P. Anthony.  Diseases of the Liver and Biliary System , 1981 .

[98]  B. Webber,et al.  Jaundice in severe bacterial infection. , 1976, Gastroenterology.

[99]  M. Escobedo,et al.  The Frequency of Jaundice in Neonatal Bacterial Infections , 1974, Clinical pediatrics.

[100]  T. Blaschke,et al.  Effects of induced fever on sulfobromophthalein kinetics in man. , 1973, Annals of internal medicine.

[101]  H. Taylor,et al.  Hepatic dysfunction associated with renal carcinoma , 1972, Cancer.

[102]  A. H. Baggenstoss,et al.  Jaundice associated with bacteremia. , 1969, Archives of internal medicine.

[103]  M. Drescher,et al.  [Therapy of hepatitis]. , 1953, Wiener klinische Wochenschrift.

[104]  M. Morgan.  Alcoholic liver disease: natural history, diagnosis, clinical features, evaluation, management, prognosis and prevention , 1999 .

[105]  Herrine,et al.  Schiff's diseases of the liver , 1999, Gastroenterology.

[106]  G. McCaughan,et al.  Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[107]  R. Moseley.  Sepsis-associated cholestasis. , 1997, Gastroenterology.

[108]  Y. Sugiyama,et al.  Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. , 1997, The American journal of physiology.

[109]  A. Hofmann,et al.  Hepatocyte transport of bile acids and organic anions in endotoxemic rats: impaired uptake and secretion. , 1997, Gastroenterology.

[110]  G. Zhou,et al.  NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. , 1997, The Journal of biological chemistry.

[111]  D. Keppler,et al.  The canalicular conjugate export pump encoded by the cmrp/cmoat gene. , 1996, Progress in liver diseases.

[112]  Silverman Ja,et al.  Regulation and function of the multidrug resistance genes in liver. , 1995 .

[113]  S. Thorgeirsson,et al.  Regulation and function of the multidrug resistance genes in liver. , 1995, Progress in liver diseases.

[114]  N. Kawada,et al.  [Drug-induced cholestasis]. , 1995, Ryoikibetsu shokogun shirizu.

[115]  G. Davis,et al.  Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. , 1994, Gastroenterology.

[116]  A. S. Warner,et al.  Extrahepatic Hodgkin's disease and cholestasis. , 1994, The American journal of gastroenterology.

[117]  P. Holt,et al.  Hepatobiliary complications of total parenteral nutrition. , 1994, Journal of clinical gastroenterology.

[118]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[119]  E. Quigley,et al.  Hepatobiliary complications of total parenteral nutrition. , 1993, Gastroenterology.

[120]  C. Kibbler.  Bacterial infection and the liver. , 1991 .

[121]  R. Goris,et al.  Etiologic factors of jaundice in severely ill patients. A retrospective study in patients admitted to an intensive care unit with severe trauma or with septic intra-abdominal complications following surgery and without evidence of bile duct obstruction. , 1988, Journal of hepatology.

[122]  J. S. Sánchez Álvarez,et al.  [Toxic and drug-induced hepatitis]. , 1988, Revista clinica espanola.

[123]  C. Bode,et al.  Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. , 1987, Journal of hepatology.

[124]  T. Leyhe,et al.  Morphologically different biopsy specimens of the human gastric mucosa. I. The use of enzymatic cell isolation for quantitative determination of parietal cells. , 1986, Pharmacology.

[125]  V. Desmet,et al.  Cholestatic features in hepatitis A. , 1986, Journal of hepatology.

[126]  S. Itoh,et al.  Liver γ-Glutamyltransferase Activity in Viral Liver Disease , 1986 .

[127]  S. Itoh,et al.  Liver gamma-glutamyltransferase activity in viral liver disease. , 1986, Digestion.

[128]  P. Latham,et al.  Hyperalimentation-associated jaundice: an example of a serum factor inducing cholestasis in rats. , 1985, The American journal of clinical nutrition.

[129]  M. Black,et al.  Drug induced liver disease. , 1983, Postgraduate medical journal.

[130]  R. Peters,et al.  Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver. , 1983, Gastroenterology.

[131]  D. Wilton,et al.  [Hepatitis A]. , 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[132]  J. Hoofnagle,et al.  Jaundice due to bacterial infection. , 1979, Gastroenterology.

[133]  J. Rankin,et al.  Alcohol and the Liver , 1977, Springer US.

[134]  R. Beran.  [Intrahepatic cholestasis]. , 1974, Wiener medizinische Wochenschrift.